Noticias HC

The most advanced radiotherapy for lung cancer

cancer de pulmonBy the end of 2021, lung cancer is expected to be one of the most commonly diagnosed tumours in Spain. However, more worrying are the mortality figures for this type of tumour, accounting for up to 20% of cancer deaths in the last year.

 

Fortunately, thanks to clinical research and the development of new technology in oncology field, there are more options than ever to deal with this disease.

 

Personalised treatment is the always the best option, adapted to the specific type of tumour (location, extent, how aggressive it is, its molecular features, etc.) but also adapted to the patients themselves, their age, health, lifestyle, etc.

 

Radiotherapy, an alternative to surgical treatment

 

Radiotherapy is one of the pillars in the multidisciplinary treatment of these tumours. The aim of treatment is curative for patients with early-stage disease who do not wish to undergo invasive surgery, it is also the best alternative for those who are not candidates for surgical treatment due to their medical history.

 

Radiotherapy offered in the early stages of cancer is known as SBRT (Stereotactic Body Radiation Therapy) and requires very precise technology for its delivery, as it targets high doses of radiation at the region to be treated, shortening treatment times and increasing the effective radiobiological dose in the tumour.

 

Radiotherapy that adapts to respiration.

radioterapia pulmon One of the biggest difficulties faced during lung treatment is the movement from breathing, the torso moves with each breath. Lung tumours therefore move continuously during treatment delivery. If the radiation beam does not adapt and synchronise to the movement of the tumour, the dose delivered to it may be insufficient, with an increase in the dose administered to surrounding healthy tissue. This can affect the overall effectiveness of treatment and potentially increase the incidence and severity of side effects.

 

Very few centres have a tumour tracking system capable of detecting movement and ensuring that the radiation beam follows the tumour in real time, without stopping treatment. But at HC we go a step further. Thanks to the Synchrony system, not only do we perform real-time tumour tracking, but our patients do not require internal fiducial markers (small seeds, generally gold and measuring millimetres in size, inserted to help externally locate the tumour) as it is simply controlled by positioning LEDs on the skin of the patient’s chest, thus avoiding the possible risks of fiducial siting and/or migration (pneumothorax). This makes us unique in Spain and places us in an international group of centres that have this incredible advanced technology.

 

Effective and minimally invasive radiotherapy.

equipo radioterapia pulmon

For those patients with locally advanced disease where radiotherapy and chemotherapy are the treatment of choice, we also continue to offer high quality, minimally invasive and highly conformal radiotherapy that adapts to the shape of the volume to be treated.

 

This allows us to apply a lower dose of radiation to healthy tissue and organs, with fewer side effects, a better quality of life and the ability to intensify treatment and increase disease control. We can therefore confront these mortality figures and continue to improve them, offering our patients the best non-invasive cancer treatment.

 
 
Dra. Paula Sedano
Dra. Paula Sedano Ferreras
Especialista en Oncología Radioterápica

 

 

November 26, 2021

 

 

Read other news

Online appointment and download of test results through My HC.

Tel.: +34 952 908 628

952908898 Oncology
951829978 Diagnosis by imaging
951829947 Gynecology
952908897 Fertility
951829947 Physiotherapy

 

     

     

    I agree to receive e-mails with offers and news about this and other services. *

    YesNo

     

    Responsible: HC Hospitales, S.L. Purpose: Managing the appointment process. Sending you information by newsletter, upon your acceptance. Duration: The data is deleted once the information has been provided to you, unless you contract our services or request us to contact you in the future. With regard to the newsletter, the data is deleted when you unsubscribe from it. Recipients: We do not disclose your data to any other party. Rights: To access, rectify, and delete your data, as well as further rights explained in the additional information webpage: https://clientes.prodat.es/privacidad/MLG/HCMARBELLA

     

    Specialized Care

    Patient Services

    HC Professionals

    Subscribe to our newsletter

    Subscribe